Our solutions are designed by clinicians working in their expert fields, and tested in the real environment before they are ready to be released. The evaluation process is based on scientific methods and in most cases the results can be found in peer-reviewed journals.
This rigorous process ensures that our solutions are usable and effective in terms of costs and clinical outcomes.
The following benefits and publications are a testament to our academic standing in antimicrobial stewardship, and demonstrate the rigor that goes into developing our tools.
all fell after Guidance was implemented. Trends in increased susceptibility of Staphylococcus aureus to methicillin and improved susceptibility of Pseudomonas spp. to many antibiotics were observed.2